Daniel Ardeljan

1.8k total citations
18 papers, 852 citations indexed

About

Daniel Ardeljan is a scholar working on Molecular Biology, Ophthalmology and Plant Science. According to data from OpenAlex, Daniel Ardeljan has authored 18 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Ophthalmology and 6 papers in Plant Science. Recurrent topics in Daniel Ardeljan's work include Retinal Diseases and Treatments (9 papers), Chromosomal and Genetic Variations (6 papers) and Ocular Diseases and Behçet’s Syndrome (5 papers). Daniel Ardeljan is often cited by papers focused on Retinal Diseases and Treatments (9 papers), Chromosomal and Genetic Variations (6 papers) and Ocular Diseases and Behçet’s Syndrome (5 papers). Daniel Ardeljan collaborates with scholars based in United States, China and Netherlands. Daniel Ardeljan's co-authors include Chi‐Chao Chan, Kathleen H. Burns, Lindsay M. Payer, Wan Rou Yang, Martin S. Taylor, David T. Ting, Jared P. Steranka, Jef D. Boeke, Jingsheng Tuo and Mones Abu‐Asab and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Daniel Ardeljan

18 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ardeljan United States 13 530 303 272 137 111 18 852
Robert J. Ross United States 12 620 1.2× 604 2.0× 180 0.7× 273 2.0× 86 0.8× 13 1.1k
Una Kelly United States 13 404 0.8× 436 1.4× 28 0.1× 190 1.4× 180 1.6× 20 783
David McGaughey United States 14 433 0.8× 58 0.2× 50 0.2× 19 0.1× 28 0.3× 20 587
Dan Yi Wang Hong Kong 15 432 0.8× 689 2.3× 13 0.0× 255 1.9× 19 0.2× 16 923
David Sprott Germany 11 165 0.3× 34 0.1× 49 0.2× 23 0.2× 107 1.0× 19 402
Ana Artero‐Castro Spain 14 550 1.0× 67 0.2× 17 0.1× 38 0.3× 61 0.5× 26 724
Sindhu Saraswathy United States 16 260 0.5× 413 1.4× 9 0.0× 143 1.0× 111 1.0× 36 666
Gail Billingsley Canada 16 727 1.4× 444 1.5× 14 0.1× 185 1.4× 14 0.1× 19 1.0k
Ponugoti Vasantha Rao United States 14 472 0.9× 154 0.5× 6 0.0× 82 0.6× 35 0.3× 43 607
Kelly Wentz‐Hunter United States 13 446 0.8× 344 1.1× 10 0.0× 105 0.8× 8 0.1× 18 684

Countries citing papers authored by Daniel Ardeljan

Since Specialization
Citations

This map shows the geographic impact of Daniel Ardeljan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ardeljan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ardeljan more than expected).

Fields of papers citing papers by Daniel Ardeljan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ardeljan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ardeljan. The network helps show where Daniel Ardeljan may publish in the future.

Co-authorship network of co-authors of Daniel Ardeljan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ardeljan. A scholar is included among the top collaborators of Daniel Ardeljan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ardeljan. Daniel Ardeljan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Antiochos, Brendan, Jessica Li, Daniel Goldman, et al.. (2021). Autoantibodies targeting LINE-1-encoded ORF1p are associated with systemic lupus erythematosus diagnosis but not disease activity. Clinical and Experimental Rheumatology. 40(9). 1636–1641. 6 indexed citations
2.
Ardeljan, Daniel, Jared P. Steranka, Chunhong Liu, et al.. (2020). Cell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication. Nature Structural & Molecular Biology. 27(2). 168–178. 80 indexed citations
3.
Ardeljan, Daniel, Xuya Wang, Martin S. Taylor, et al.. (2019). LINE-1 ORF2p expression is nearly imperceptible in human cancers. Mobile DNA. 11(1). 1–1. 39 indexed citations
4.
Yang, Wan Rou, et al.. (2019). SQuIRE reveals locus-specific regulation of interspersed repeat expression. Nucleic Acids Research. 47(5). e27–e27. 114 indexed citations
5.
Payer, Lindsay M., Jared P. Steranka, Daniel Ardeljan, et al.. (2018). Aluinsertion variants alter mRNA splicing. Nucleic Acids Research. 47(1). 421–431. 56 indexed citations
6.
Ardeljan, Daniel, Martin S. Taylor, David T. Ting, & Kathleen H. Burns. (2017). The Human Long Interspersed Element-1 Retrotransposon: An Emerging Biomarker of Neoplasia. Clinical Chemistry. 63(4). 816–822. 97 indexed citations
7.
Payer, Lindsay M., Jared P. Steranka, Wan Rou Yang, et al.. (2017). Structural variants caused byAluinsertions are associated with risks for many human diseases. Proceedings of the National Academy of Sciences. 114(20). E3984–E3992. 86 indexed citations
8.
Ardeljan, Daniel, Martin S. Taylor, Kathleen H. Burns, et al.. (2016). Meeting Report: The Role of the Mobilome in Cancer. Cancer Research. 76(15). 4316–4319. 2 indexed citations
9.
Chan, Chi‐Chao & Daniel Ardeljan. (2014). Molecular Pathology of Macrophages and Interleukin-17 in Age-Related Macular Degeneration. Advances in experimental medicine and biology. 801. 193–198. 34 indexed citations
10.
11.
Ardeljan, Daniel, et al.. (2014). Inflammation and Cell Death in Age-Related Macular Degeneration: An Immunopathological and Ultrastructural Model. Journal of Clinical Medicine. 3(4). 1542–1560. 43 indexed citations
12.
Ardeljan, Daniel, Yujuan Wang, De Fen Shen, et al.. (2013). Interleukin-17 neutralization ameliorates retinal degeneration in Cx3cr1-/-/Ccl2-/-/Crb1rd8 mice. Investigative Ophthalmology & Visual Science. 54(15). 1713–1713. 2 indexed citations
13.
Ardeljan, Daniel, Catherine Meyerle, Elvira Agrón, et al.. (2013). Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration. European Journal of Human Genetics. 21(10). 1152–1157. 22 indexed citations
14.
Ardeljan, Daniel & Chi‐Chao Chan. (2013). Aging is not a disease: Distinguishing age-related macular degeneration from aging. Progress in Retinal and Eye Research. 37. 68–89. 177 indexed citations
15.
Ardeljan, Daniel, Yujuan Wang, De Fen Shen, Jingsheng Tuo, & Chi‐Chao Chan. (2012). Treatment With Recombinant Interleukin-17A Reduces ARPE-19 Cell Viability. Investigative Ophthalmology & Visual Science. 53(14). 1227–1227. 2 indexed citations
16.
Chu, Xi, et al.. (2012). Controversial view of a genetically altered mouse model of focal retinal degeneration. Bioengineered. 4(3). 130–135. 24 indexed citations
17.
Rosen, Richard B., Catherine Meyerle, Shree K. Kurup, et al.. (2012). Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.. PubMed. 18. 2578–85. 20 indexed citations
18.
Ardeljan, Daniel, Jingsheng Tuo, & Chi‐Chao Chan. (2011). Carboxyethylpyrrole plasma biomarkers in age-related macular degeneration. Drugs of the Future. 36(9). 712–712. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert J. Ross Breakdown of academic impact, for papers by Una Kelly Breakdown of academic impact, for papers by David McGaughey Breakdown of academic impact, for papers by Dan Yi Wang Breakdown of academic impact, for papers by David Sprott Breakdown of academic impact, for papers by Ana Artero‐Castro Breakdown of academic impact, for papers by Sindhu Saraswathy Breakdown of academic impact, for papers by Gail Billingsley Breakdown of academic impact, for papers by Ponugoti Vasantha Rao Breakdown of academic impact, for papers by Kelly Wentz‐Hunter
Rankless by CCL
2026